About Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation
Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation is a rare disease catalogued by Orphanet (ORPHA:254534). It is associated with the DLK1, MEG3, RTL1 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation trials.
Search ClinicalTrials.gov for "Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation" or filter by Orphanet code ORPHA:254534 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation. Updated daily.